Enabling gene therapy to express itself

Nucleic Acid Transfer

Lamellar Biomedical’s LAMELLASOME™ Nucleic Acid Transfer technology delivers nucleic...

Products in Development

LAMELLASOME formulations have been shown to be effective in delivering functional nucleic acids...

Partnering Opportunities

Safe and effective delivery is clearly a challenge for the many types of active agent...

Mar 13, 2019

Lamellar Biomedical partners with two leading Scottish universities to further optimise its LAMELLASOME™ Nucleic Acid delivery platform

Jan 4, 2019

Lamellar to conduct Business Development Meetings about LAMELLASOME™ technology at Biotech Showcase in San Francisco

Nov 1, 2018

Lamellar Biomedical Submits Patent for LAMELLASOME™ platform for the safe and effective delivery of nucleic acid based therapeutics

Oct 29, 2018

Lamellar to introduce its LAMELLASOME™ nucleic acid transfer technology at BIO-Europe 2018 in Copenhagen

  Read More
Lamellar Pipeline
  Read More
  Read More
© Copyright 2019 Lamellar